Archives: CounselingConnection

Differentiating Approved COVID-19 Vaccines and Boosters

On December 11, 2020, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the first vaccine against COVID-19, the Pfizer-BioNTech COVID-19 vaccine.1 This announcement was quickly followed by EUAs of the Moderna COVID-19 vaccine on December 18, 2020, and the Johnson & Johnson COVID-19 vaccine on February 27, 2021.2,3 Most mass…

Guide for Management of Moderate to Severe Plaque Psoriasis: Counseling for Patients Who Have Failed Therapy

Psoriasis is a chronic inflammatory disorder that affects approximately 3.2% of the US population.1 Although psoriasis was long considered to affect only the skin and joints, its underlying cause involves helper T-cell type 1 (TH1) immune dysregulation that can affect other organ systems.2 Individuals with psoriasis are at increased risk for cardiovascular disease, hypertension, and…

Next counselingconnection in Counseling Connection